Editas Medicine

$Prime Medicine(PRME)$ $Intellia(NTLA)$ $Editas Medicine(EDIT)$ 体内递送技术取得新突破：SORT LNP 递送 Cas9 mRNA，可高效编辑肌营养不良模型中的骨骼肌。无需病毒载体，免疫原性低，即可恢复 40% 的 Telethonin 表达！在肌营养不良症治疗中具有巨大潜力。该技术的突破有利于做体内基因编辑的...

$Editas Medicine(EDIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001650664-26-000007  Size: 5 KB 网页链接

$Editas Medicine(EDIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001650664-26-000021  Size: 5 KB 网页链接

$Editas Medicine(EDIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001650664-26-000006  Size: 5 KB 网页链接

$Editas Medicine(EDIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001650664-26-000009  Size: 5 KB 网页链接

$Editas Medicine(EDIT)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001650664-26-000017  Act: 34  Size: 11 MB 网页链接

$Editas Medicine(EDIT)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-001154  Act: 34  Size: 7 KB 网页链接

$Editas Medicine(EDIT)$ 144 Report of proposed sale of securities Accession Number: 0001650664-26-000002  Act: 33  Size: 4 KB 网页链接

$Editas Medicine(EDIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001650664-26-000022  Size: 5 KB 网页链接

$Editas Medicine(EDIT)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001650664-26-000027  Act: 34  Size: 181 KB 网页链接

$Editas Medicine(EDIT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001650664-26-000013  Act: 34  Size: 325 KB 网页链接

$Editas Medicine(EDIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001650664-26-000023  Size: 5 KB 网页链接